Pricing

Honest pricing, no surprises

Cash programs are flat-rate. Spravato is run through your insurance, including prior authorization.

At-Home Ketamine
Cash
~$349/ month avg.

Sublingual maintenance after in-clinic induction. See full fee schedule below for exact per-service rates.

  • In-person evaluation
  • Supervised induction
  • Peer-monitored home sessions
  • Virtual check-ins & messaging
Choose this program
IV Ketamine
Cash · Featured
$450/ infusion

Series typically 6 infusions over 2–3 weeks.

  • Continuous vitals monitoring
  • Private recovery suite
  • Physician oversight each visit
  • Booster infusions available
Choose this program
Spravato®
Insurance-based
Insurance

FDA-approved esketamine — administered under REMS.

  • REMS-certified site
  • 2-hour monitored observation
  • Prior-authorization handled
  • Coordinated with your prescriber
Check my coverage
Medicare welcome

Spravato on a buy & bill basis

We bill Spravato directly to Medicare. Treatment begins with a one-time $900 deposit, applied toward your ongoing Spravato course. IV and at-home ketamine are not covered by Medicare and remain private pay at standard rates.

Start with Medicare
Fee schedule

Cash-pay rates by service code

At-home ketamine averages ~$349/month across most patients. Your actual monthly cost depends on visit cadence and which services you use. Below are the exact rates for every service we bill — no surprises.

CodeServiceDurationRate
99205Initial psychiatric evaluation (60 min)$495
99214Telehealth follow-up (25 min)$225
DISP-TRCompounded troche dispense (per cycle)$180
KAP-INDKetamine-assisted induction session (in-clinic)$650
PMR-15Peer monitor review & approval$75
REEVAL-9090-day re-evaluation & treatment plan review$325
TRL-INITInitial evaluation60 min$450
TRL-INDInduction session90 min$525
TRL-MAINTMaintenance — at-home dose$175
TRL-REEVAL90-day re-evaluation45 min$275
TRL-TELETelehealth follow-up30 min$165
TRL-AEAdverse-event consult30 minno charge

Sample pricing shown — final rates confirmed at evaluation. Spravato coverage and copays vary by individual insurance plan.

Physician-led ketamine and Spravato therapy held together by one careful pathway.

Medical disclaimer. Ketamine and Spravato® are prescription medicines. At-home and IV ketamine are administered off-label for mood and pain conditions; Spravato® (esketamine) is FDA-approved for treatment-resistant depression and administered under a REMS program. All treatment requires an in-person physician evaluation and ongoing clinical oversight. This page is educational and does not constitute medical advice. Results vary; treatment may not be appropriate for every patient. If you are in crisis, call or text 988.